Form 4 for ADCT ADC Therapeutics SA
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-13 · accession 0001628280-26-009275 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | 2026-02-13 | ADCT | MALLIK AMEET | CEO, Dir | F - Tax | $3.99 | -103.2K | 1.45M | -7% | -$411.9K | |
| 2026-02-18 | 2026-02-13 | ADCT | MALLIK AMEET | CEO, Dir | A - Grant | $3.99 | +900.0K | 1.55M | +138% | +$3.59M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-02-13 | F | D | 103,231 | $3.99 | 1,446,769 | D | — | — | (F3) Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted. |
| 2 | Common | Common Shares | 2026-02-13 | A | A | 900,000 | $3.99 | 1,550,000 | D | — | — | (F1) Represents Common Shares to be delivered in settlement of a restricted share unit award which vests one-third on the first anniversary of the grant date, which grant date is February 13, 2026, and then one-third on each anniversary date thereafter, upon continued service through the designated vesting event. (F2) Balance reflects the prior transfer of 669,101 Common Shares from the Reporting Person to a grantor retained annuity trust, which transfer is exempt from Section 16(b) pursuant to Rule 16a-13. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |